Drug Type Radiolabeled antibody, Therapeutic radiopharmaceuticals |
Synonyms 177LU-U33 IGG |
Target |
Action modulators |
Mechanism Plasminogen activators modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Discovery | United States | - | |
Prostatic Cancer | Discovery | United States | - |